Preliminary results on novel adjuvant combinations suggest enhanced immunogenicity of whole inactivated pandemic influenza vaccines
CORRECTION article
Corrigendum: Preliminary results on novel adjuvant combinations
Provisionally accepted- 1 Biopharmaceutics School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland
- 2 Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
Corrigendum: Preliminary results on novel adjuvant combinations
Keywords: pandemic influenza, saponin, Tomatine, Vaccines, PLGA, nanoparticle
Received: 30 Oct 2024; Accepted: 03 Dec 2024.
Copyright: © 2024 Peletta, Marmy, Guzelj, Ramos Barros, Jakopin and Borchard. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Allegra Peletta, Biopharmaceutics School of Pharmaceutical Sciences, University of Geneva, Geneva, 1211, Switzerland
Gerrit Borchard, Biopharmaceutics School of Pharmaceutical Sciences, University of Geneva, Geneva, 1211, Switzerland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.